Publications
Diabetic nephropathy and proton pump inhibitors - pilot case-control study
Jeffrey Pradeep Raj 1, Reevan Winston Pinto 1, Suraj Kallarakal Tomy 1, Shruthi M Kulkarni 2,✉ Abstract
Introduction:
Proton pump inhibitors (PPIs) are liberally used over the counter medication and is largely considered safe. Off late, there are many reports that suggest increased incidence of chronic kidney disease with long-term PPI use. PPIs are often prescribed in patients with diabetes mellitus (DM) and one of the well-known complications of DM is diabetic nephropathy (DN). Thus, the aim of our study was to evaluate association between PPI use and DN.
